CAS 1009119-83-8

1H-Imidazole, 5,5′-[1,1′-biphenyl]-4,4′-diylbis[2-(2S)-2-pyrrolidinyl-, hydrochloride (1:4)

Description:

1H-Imidazole, 5,5′-[1,1′-biphenyl]-4,4′-diylbis[2-(2S)-2-pyrrolidinyl-, hydrochloride (1:4), identified by its CAS number 1009119-83-8, is a complex organic compound characterized by its imidazole and biphenyl moieties, along with pyrrolidine substituents. This compound typically exhibits properties associated with both basic and aromatic functionalities, which may contribute to its potential biological activity. The presence of the imidazole ring suggests possible interactions with biological targets, particularly in enzymatic or receptor binding processes. The hydrochloride form indicates that it is a salt, which can enhance its solubility in aqueous environments, making it suitable for various applications in medicinal chemistry. Additionally, the stereochemistry of the pyrrolidine units may influence its pharmacokinetic properties and biological interactions. Overall, this compound's structural complexity and functional groups suggest potential utility in pharmaceutical research, particularly in the development of novel therapeutic agents.

Formula: C₂₆H₂₈N₆·4ClH

InChI: InChI=1S/C26H28N6.4ClH/c1-3-21(27-13-1)25-29-15-23(31-25)19-9-5-17(6-10-19)18-7-11-20(12-8-18)24-16-30-26(32-24)22-4-2-14-28-22;;;;/h5-12,15-16,21-22,27-28H,1-4,13-14H2,(H,29,31)(H,30,32);4*1H/t21-,22-;;;;/m0..../s1

InChI key: InChIKey=AYOXSBJGFNPGNK-VDUNKYASSA-N

SMILES: C=1(NC(=NC1)[C@@H]2CCCN2)C3=CC=C(C=C3)C4=CC=C(C=C4)C=5NC(=NC5)[C@@H]6CCCN6.Cl

Synonyms:

• 5,5'-[1,1'-Biphenyl]-4,4'-diylbis[2-(2S)-2-pyrrolidinyl-1H-imidazole] hydrochloride
• Daclatasvir intermediate-5
• 1H-Imidazole, 5,5'-[1,1'-biphenyl]-4,4'-diylbis[2-(2S)-2-pyrrolidinyl-, hydrochloride(1:4)
• 1H-Imidazole, 5,5′-[1,1′-biphenyl]-4,4′-diylbis[2-(2S)-2-pyrrolidinyl-, hydrochloride (1:4)
• 1H-Imidazole,5,5'-[1,1'-biphenyl]-4,4'-​ diylbis[2-(2S)-2-pyrrolidinyl-,hydrochloride (1:4)
• 1H-Imidazole, 5,5'-[1,1'-biphenyl]-4,4'-diylbis[2-(2S)-2-pyrrolidinyl-, hydrochloride (1:4)
• 1H-IMidazole,5,5'-[1,1'-biphenyl]-4,4'-diylbis[2-(2S)-2-pyrrolidinyl-, hydrochloride (1:4)

1H-IMidazole, 5,5'-[1,1'-biphenyl]-4,4'-diylbis[2-(2S)-2-pyrrolidinyl-, hydrochloride (1:4)

CAS: 1009119-83-8

Formula: C₂₆H₃₂Cl₄N₆

Purity: 98%

Color and Shape: Solid

Molecular weight: 570.3845

Ref: IN-DA00036H

HCV-IN-29

CAS: 1009119-83-8

HCV-IN-29 is a hepatitis C virus (HCV) inhibitor.

Formula: C₂₆H₃₂Cl₄N₆

Purity: 99.89%

Color and Shape: Solid

Molecular weight: 570.38

Ref: TM-T11539

HCV-IN-29

CAS: 1009119-83-8

HCV-IN-29

Purity: ≥98%

Molecular weight: 570.38g/mol

Ref: 54-BUP16144

4,4'-Bis(2-((S)-Pyrrolidin-2-yl)-1H-Imidazol-5-yl)-1,1'-Biphenyl Tetrahydrochloride

CAS: 1009119-83-8

4,4'-Bis(2-((S)-Pyrrolidin-2-yl)-1H-Imidazol-5-yl)-1,1'-Biphenyl Tetrahydrochloride

Purity: 98%

Molecular weight: 570.39g/mol

Ref: 54-OR1011297

Daclatasvir Impurity 10 TetraHCl

CAS: 1009119-83-8

Formula: C₂₆H₂₈N₆·4HCl

Color and Shape: Pale Yellow Solid

Molecular weight: 424.55 4*36.46

Ref: 4Z-D-145009

4,4'-Bis(2-((S)-Pyrrolidin-2-yl)-1H-imidazol-5-yl)-1,1'-biphenyl Tetrahydrochloride

CAS: 1009119-83-8

Formula: C₂₆H₂₈N₆·4HCl

Color and Shape: Neat

Ref: TR-B397775

Daclatasvir Impurity 5

CAS: 1009119-83-8

Formula: C₂₆H₂₈N₆HCl

Molecular weight: 424.6 : 4(36.46)

Ref: ST-EA-CP-D71021

1H-Imidazole, 5,5’-[1,1’-biphenyl]-4,4’-diylbis[2-(2S)-2-pyrrolidinyl-, hydrochloride

CAS: 1009119-83-8

Intermediate in the synthesis of daclatasvir

Formula: C₂₆H₂₉ClN₆

Purity: Min. 95%

Molecular weight: 461 g/mol

Ref: 3D-FI143880